RNA processing and clinical variability in neurofibromatosis type I (NF1)

Human Molecular Genetics

Volumn 6, Issue 10 REV. ISS., 1997, Pages 1707-1712

  Skuse, Gary R ^a   Cappione, Amedeo J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MESSENGER RNA; NEUROFIBROMIN; RAS PROTEIN;

ALLELE; ALTERNATIVE RNA SPLICING; ARTICLE; CELL CULTURE; CELL GROWTH; CLINICAL FEATURE; DEVELOPMENT; DISEASE SEVERITY; GENE FUNCTION; GENETIC VARIABILITY; GROWTH REGULATION; HUMAN; HUMAN CELL; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA EDITING; RNA PROCESSING; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE;

ALLELES; ALTERNATIVE SPLICING; GENES, TUMOR SUPPRESSOR; HUMANS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; PROTEIN BIOSYNTHESIS; PROTEINS; RNA EDITING; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0030823760     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.10.1707     Document Type: Article

References (15)

1. Huson, S.M. (1994) In Huson, S.M. and Hughes, R.A.C., eds, The Neurofibromatoses: A Pathogenetic and Clinical Overview, 2nd edn. Chapman and Hall, London, pp. 160-179.
2. Easton, D.F., Ponder, M.A., Huson, S.M. and Ponder, B.A. (1993) An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am. J. Hum. Genet. 53, 305-313.
3. von Deimling, A., Krone, W. and Menon, A.G. (1995) Neurofibromatosis type 1: Pathology, clinical features and genetics. Brain Pathol. 5, 153-162.
4. Shen, M.H., Harper, P.S. and Upadhyaya, M. (1996) Molecular genetics of neurofibromatosis type 1 (NF1). J. Med. Genet. 33, 2-17.
5. Goldberg, Y., Dibbern, K., Klein, J., Riccardi, V.M. and Graham, J.M. (1996) Neurofibromatosis type 1 - an update and review for the primary pediatrician. Clin. Pediatr. 35, 545-561.
6. Neurofibromatosis (1988) Conference statement. National Institutes of Health Consensus Development Conference. Arch. Neurol. 45, 575-578.
7. Riccardi, V.M. and Eichner, J.E. (1986) Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore, MD: Johns Hopkins University Press, pp. 214-226.
8. Crowe, F.W., Schull, W.J. and Neel, J.V. (1956) A Clinical. Pathological, and Genetic Study of Multiple Neurofibromatosis. Springfield, IL: Thomas, pp. 142-146.
9. Huson, S.M., Compston, D.A.S., Clark, P. and Harper, P.S. (1989) A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J. Med. Genet. 26, 701-711.
10. Metheny, L.J., Cappione, A.J. and Skuse, G.R. (1995) Genetic and epigenetic mechanisms in the pathogenesis of neurofibromatosis type I. J. Neuropathol. Exp. Neurol. 54, 753-760.
11. Li, Y, O'Connell, P., Breidenbach, H.H., Cawthon, R., Stevens, J., Xu, G., Neil, S., Robertson, M., White, R. and Viskochil, D. (1995) Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 25, 9-18.
12. Marchuk, D.A., Saulino, A.M., Tavakkol, R., Swaroop, M., Wallace, M.R., Andersen, L.B., Mitchell, A.L., Gutmann, D.H., Boguski, M. and Collins, ES. (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11, 931-940.
13. Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M. and Collins, F. (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63, 851-857.
14. Xu, G.F., O'Connell, P., Viscochil, D., Cawthon, M., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R. and Weiss, R. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62, 599-608.
15. Buchberg, A.M., Cleveland, L.S., Jenkins, N.A. and Copeland N.G. (1990) Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature 347, 291-294.